Clindamycin Oral capsule 300mg Information - Conditions, Pregnancy, ingredients
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

Clindamycin: Oral capsule (300mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Most Commonly Used
Drug Image file DrugItem_3172.JPG
Clindamycin 300mg Cap
Ranbaxy Pharmaceuticals Inc
Pill Identification: RX693 RX693 
Drug Image file default-drug-image.png
Clindamycin 300mg Cap
Drug Image file DrugItem_730.JPG
Clindamycin 300mg Cap
Greenstone Ltd
Pill Identification: G 300 mg 5010 
Drug Image file DrugItem_14712.JPG
Clindamycin 300mg Cap
Actavis Pharma, Inc., formerly Watson Pharmaceuticals Inc
Pill Identification: DAN 3120 DAN 3120 
Drug Image file default-drug-image.png
Clindamycin 300mg Cap

What is this Medicine?

CLINDAMYCIN (KLIN da MYE sin) is a lincosamide antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

Similar Brand Name Drugs : Cleocin: Oral capsule(150mg)
CVS/pharmacy Patient Statistics for Clindamycin: Oral capsule(300mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Clindamycin Hydrochloride 300mg Capsule

NDC: 633040693
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bacteremia, Pelvic Cellulitis, Peritonitis, Aspiration Pneumonia, Pneumonia, Empyema, Impetigo, Intraabdominal Infections, Bone And Joint Infections, Septicemia, Intraabdominal Abscess, Infectious Arthritis, Osteomyelitis, Pelvic Inflammatory Disease (PID), Gynecologic Infections, Cellulitis, Skin And Skin Structure Infections, Endometritis, Lower Respiratory Tract Infections, Tubo-ovarian Abscess, Lung Abscess, Community-acquired Pneumonia

Sometimes used for but not FDA approved for the following conditions:
Babesiosis, Pneumocystis Pneumonia (PCP), Bone And Joint Infections, Endocarditis Prophylaxis, Dental Infection, Infectious Arthritis, Pharyngitis, Toxoplasmosis, Dental Abscess (apical), Dentoalveolar Infection, Toxoplasmic Encephalitis, Dental Abscess (periapical), Osteomyelitis, Periodontitis, Otitis Media, Rheumatic Fever Prophylaxis, Toxoplasmosis Prophylaxis, Malaria, Orthopedic Device-related Infection, Bacterial Colonization Eradication, Endodontic Infection, Sinusitis, Bacterial Vaginosis

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Clindamycin Hydrochloride 300mg Capsule
Drug Image file DrugItem_3172.JPG
Ranbaxy Pharmaceuticals Inc
Pill Identification: RX693 RX693 
Shape: capsule
Color: blue

Reported Side Effects for Clindamycin Hydrochloride 300mg Capsule

Infection Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Drug Reaction With Eosinophilia And Systemic Symptoms (DRESS) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Yeast Infection Incidence:
<14.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<20.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<11.0%*
Severity: MILD
Onset: RAPID
Pseudomembranous Colitis Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Vaginal Infection Incidence:
<3.6%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Clindamycin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.